Global Insomnia Market Size, Share & Industry Trends Analysis Report By Distribution Channel (Hospital, Retail, and Others), By Therapy Type (Pharmacological and Non-Pharmacological), By Regional Outlook and Forecast, 2022 - 2028

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Insomnia Market, by Distribution Channel
1.4.2 Global Insomnia Market, by Therapy Type
1.4.3 Global Insomnia Market, by Geography
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Strategies deployed in Insomnia Market

Chapter 4. Global Insomnia Market by Distribution Channel
4.1 Global Hospital Market by Region
4.2 Global Retail Market by Region
4.3 Global Others Market by Region

Chapter 5. Global Insomnia Market by Therapy Type
5.1 Global Pharmacological Market by Region
5.2 Global Non-Pharmacological Market by Region

Chapter 6. Global Insomnia Market by Region
6.1 North America Insomnia Market
6.1.1 North America Insomnia Market by Distribution Channel
6.1.1.1 North America Hospital Market by Country
6.1.1.2 North America Retail Market by Country
6.1.1.3 North America Others Market by Country
6.1.2 North America Insomnia Market by Therapy Type
6.1.2.1 North America Pharmacological Market by Country
6.1.2.2 North America Non-Pharmacological Market by Country
6.1.3 North America Insomnia Market by Country
6.1.3.1 US Insomnia Market
6.1.3.1.1 US Insomnia Market by Distribution Channel
6.1.3.1.2 US Insomnia Market by Therapy Type
6.1.3.2 Canada Insomnia Market
6.1.3.2.1 Canada Insomnia Market by Distribution Channel
6.1.3.2.2 Canada Insomnia Market by Therapy Type
6.1.3.3 Mexico Insomnia Market
6.1.3.3.1 Mexico Insomnia Market by Distribution Channel
6.1.3.3.2 Mexico Insomnia Market by Therapy Type
6.1.3.4 Rest of North America Insomnia Market
6.1.3.4.1 Rest of North America Insomnia Market by Distribution Channel
6.1.3.4.2 Rest of North America Insomnia Market by Therapy Type
6.2 Europe Insomnia Market
6.2.1 Europe Insomnia Market by Distribution Channel
6.2.1.1 Europe Hospital Market by Country
6.2.1.2 Europe Retail Market by Country
6.2.1.3 Europe Others Market by Country
6.2.2 Europe Insomnia Market by Therapy Type
6.2.2.1 Europe Pharmacological Market by Country
6.2.2.2 Europe Non-Pharmacological Market by Country
6.2.3 Europe Insomnia Market by Country
6.2.3.1 Germany Insomnia Market
6.2.3.1.1 Germany Insomnia Market by Distribution Channel
6.2.3.1.2 Germany Insomnia Market by Therapy Type
6.2.3.2 UK Insomnia Market
6.2.3.2.1 UK Insomnia Market by Distribution Channel
6.2.3.2.2 UK Insomnia Market by Therapy Type
6.2.3.3 France Insomnia Market
6.2.3.3.1 France Insomnia Market by Distribution Channel
6.2.3.3.2 France Insomnia Market by Therapy Type
6.2.3.4 Russia Insomnia Market
6.2.3.4.1 Russia Insomnia Market by Distribution Channel
6.2.3.4.2 Russia Insomnia Market by Therapy Type
6.2.3.5 Spain Insomnia Market
6.2.3.5.1 Spain Insomnia Market by Distribution Channel
6.2.3.5.2 Spain Insomnia Market by Therapy Type
6.2.3.6 Italy Insomnia Market
6.2.3.6.1 Italy Insomnia Market by Distribution Channel
6.2.3.6.2 Italy Insomnia Market by Therapy Type
6.2.3.7 Rest of Europe Insomnia Market
6.2.3.7.1 Rest of Europe Insomnia Market by Distribution Channel
6.2.3.7.2 Rest of Europe Insomnia Market by Therapy Type
6.3 Asia Pacific Insomnia Market
6.3.1 Asia Pacific Insomnia Market by Distribution Channel
6.3.1.1 Asia Pacific Hospital Market by Country
6.3.1.2 Asia Pacific Retail Market by Country
6.3.1.3 Asia Pacific Others Market by Country
6.3.2 Asia Pacific Insomnia Market by Therapy Type
6.3.2.1 Asia Pacific Pharmacological Market by Country
6.3.2.2 Asia Pacific Non-Pharmacological Market by Country
6.3.3 Asia Pacific Insomnia Market by Country
6.3.3.1 China Insomnia Market
6.3.3.1.1 China Insomnia Market by Distribution Channel
6.3.3.1.2 China Insomnia Market by Therapy Type
6.3.3.2 Japan Insomnia Market
6.3.3.2.1 Japan Insomnia Market by Distribution Channel
6.3.3.2.2 Japan Insomnia Market by Therapy Type
6.3.3.3 India Insomnia Market
6.3.3.3.1 India Insomnia Market by Distribution Channel
6.3.3.3.2 India Insomnia Market by Therapy Type
6.3.3.4 South Korea Insomnia Market
6.3.3.4.1 South Korea Insomnia Market by Distribution Channel
6.3.3.4.2 South Korea Insomnia Market by Therapy Type
6.3.3.5 Singapore Insomnia Market
6.3.3.5.1 Singapore Insomnia Market by Distribution Channel
6.3.3.5.2 Singapore Insomnia Market by Therapy Type
6.3.3.6 Malaysia Insomnia Market
6.3.3.6.1 Malaysia Insomnia Market by Distribution Channel
6.3.3.6.2 Malaysia Insomnia Market by Therapy Type
6.3.3.7 Rest of Asia Pacific Insomnia Market
6.3.3.7.1 Rest of Asia Pacific Insomnia Market by Distribution Channel
6.3.3.7.2 Rest of Asia Pacific Insomnia Market by Therapy Type
6.4 LAMEA Insomnia Market
6.4.1 LAMEA Insomnia Market by Distribution Channel
6.4.1.1 LAMEA Hospital Market by Country
6.4.1.2 LAMEA Retail Market by Country
6.4.1.3 LAMEA Others Market by Country
6.4.2 LAMEA Insomnia Market by Therapy Type
6.4.2.1 LAMEA Pharmacological Market by Country
6.4.2.2 LAMEA Non-Pharmacological Market by Country
6.4.3 LAMEA Insomnia Market by Country
6.4.3.1 Brazil Insomnia Market
6.4.3.1.1 Brazil Insomnia Market by Distribution Channel
6.4.3.1.2 Brazil Insomnia Market by Therapy Type
6.4.3.2 Argentina Insomnia Market
6.4.3.2.1 Argentina Insomnia Market by Distribution Channel
6.4.3.2.2 Argentina Insomnia Market by Therapy Type
6.4.3.3 UAE Insomnia Market
6.4.3.3.1 UAE Insomnia Market by Distribution Channel
6.4.3.3.2 UAE Insomnia Market by Therapy Type
6.4.3.4 Saudi Arabia Insomnia Market
6.4.3.4.1 Saudi Arabia Insomnia Market by Distribution Channel
6.4.3.4.2 Saudi Arabia Insomnia Market by Therapy Type
6.4.3.5 South Africa Insomnia Market
6.4.3.5.1 South Africa Insomnia Market by Distribution Channel
6.4.3.5.2 South Africa Insomnia Market by Therapy Type
6.4.3.6 Nigeria Insomnia Market
6.4.3.6.1 Nigeria Insomnia Market by Distribution Channel
6.4.3.6.2 Nigeria Insomnia Market by Therapy Type
6.4.3.7 Rest of LAMEA Insomnia Market
6.4.3.7.1 Rest of LAMEA Insomnia Market by Distribution Channel
6.4.3.7.2 Rest of LAMEA Insomnia Market by Therapy Type

Chapter 7. Company Profiles
7.1 Eisai Co., Ltd.
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expenses
7.1.5 Recent strategies and developments:
7.1.5.1 Product Launches and Product Expansions:
7.1.5.2 Approvals and Trails:
7.2 Takeda Pharmaceutical Company Limited
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Regional Analysis
7.2.4 Research & Development Expense
7.2.5 Recent strategies and developments:
7.2.5.1 Approvals and Trails:
7.3 Vanda Pharmaceuticals, Inc.
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Research & Development Expenses
7.3.4 Recent strategies and developments:
7.3.4.1 Approval and Trails:
7.4 Cadila Healthcare Ltd. (Zydus Cadila)
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expense
7.4.5 Recent strategies and developments:
7.4.5.1 Product Launches and Product Expansions:
7.5 Sanofi S.A.
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expense
7.5.5 Recent strategies and developments:
7.5.5.1 Geographical Expansions:
7.6 Merck Group
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expense
7.7 Pfizer, Inc.
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Regional & Segmental Analysis
7.7.4 Research & Development Expense
7.8 Viatris, Inc.
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental and Regional Analysis
7.8.4 Research & Development Expense
7.9 Currax Pharmaceuticals LLC (Currax Holdings USA LLC)
7.9.1 Company Overview
7.9.2 Recent strategies and developments:
7.9.2.1 Acquisition and Mergers:
7.9.2.2 Geographical Expansions:
7.10. Purdue Pharma L.P.
7.10.1 Company Overview